The RAS-BRAF kinase pathway is not involved in uveal melanoma
Authors:
- Emine KlçEKEmine Klç
- Hennie T. BrüggenwirthHBHennie T. Brüggenwirth
- Michael M.P.J. VerbiestMVMichael M.P.J. Verbiest
- Ellen C. ZwarthoffEZEllen C. Zwarthoff
- Neeltje M. MooyNMNeeltje M. Mooy
- Gre P.M. LuytenGLGre P.M. Luyten
- Annelies de KleinAKAnnelies de Klein
- 1 June 2004
- journal article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 14 (3) , 203-205
Abstract
An activating mutation has been recently observed in cutaneous melanoma in a downstream component of RAS-BRAF. The most common mutation, occurring in 80% of cutaneous melanoma samples, is a T-to-A transition resulting in a single amino acid substitution (V599E). Since cutaneous and uveal melanoma (UM) have a common origin, we aimed to establish whether activation of the BRAF proto-oncogene is also an important factor in the development of UM. Exons 11 through 18 of the BRAF gene were screened from 33 primary UMs and 11 UM cell lines. Genomic polymerase chain reaction products were evaluated using single-strand conformation polymorphism analysis, followed by sequencing of aberrant products. The most common mutation, T1796A in the kinase domain of BRAF, was not observed in any of the primary UM samples. This mutation was also absent in 10 of the 11 UM cell lines. In one of the UM cell lines, OCM1, the T1796A mutation was present. We conclude that, in contrast to cutaneous melanoma, BRAF does not appear to be involved in the pathogenesis of UM.Keywords
This publication has 11 references indexed in Scilit:
- Mechanisms of regulating the Raf kinase familyCellular Signalling, 2003
- Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomasBritish Journal of Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- The Raf/MEK/ERK pathway: new concepts of activationBiology of the Cell, 2001
- Activation of B‐Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601The EMBO Journal, 2000
- Mutation analysis of thePTEN gene in uveal melanoma cell linesInternational Journal of Cancer, 2000
- Analysis of N-ras Mutations in Human Cutaneous Melanoma: Tumor Heterogeneity Detected by Polymerase Chain Reaction/Single-Stranded Conformation Polymorphism Analysis1995
- Point mutations in the N-ras oncogene in malignant melanoma and congenital naeviBritish Journal of Dermatology, 1994
- No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisitedBritish Journal of Cancer, 1991
- ras GENESAnnual Review of Biochemistry, 1987